Form 8-K - Current report:
SEC Accession No. 0001193125-23-022773
Filing Date
2023-02-02
Accepted
2023-02-02 16:29:58
Documents
18
Period of Report
2023-02-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d452367d8k.htm   iXBRL 8-K 27262
2 EX-99.1 d452367dex991.htm EX-99.1 103256
3 EX-99.2 d452367dex992.htm EX-99.2 148189
8 GRAPHIC g452367g0201205527357.jpg GRAPHIC 5594
9 GRAPHIC g452367snapb3.jpg GRAPHIC 3372
10 GRAPHIC g452367sp04.jpg GRAPHIC 6578
  Complete submission text file 0001193125-23-022773.txt   494660

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sclx-20230202.xsd EX-101.SCH 4468
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclx-20230202_def.xml EX-101.DEF 13851
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclx-20230202_lab.xml EX-101.LAB 23216
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclx-20230202_pre.xml EX-101.PRE 14819
12 EXTRACTED XBRL INSTANCE DOCUMENT d452367d8k_htm.xml XML 5800
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 23581313
SIC: 2836 Biological Products, (No Diagnostic Substances)